Innoviva (INVA) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Innoviva (INVA) over the last 16 years, with Q3 2025 value amounting to $1.08.
- Innoviva's EPS (Weighted Average and Diluted) rose 530000.0% to $1.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.13, marking a year-over-year increase of 2417.58%. This contributed to the annual value of $0.36 for FY2024, which is 8363.64% down from last year.
- Innoviva's EPS (Weighted Average and Diluted) amounted to $1.08 in Q3 2025, which was up 530000.0% from $0.77 recorded in Q2 2025.
- In the past 5 years, Innoviva's EPS (Weighted Average and Diluted) registered a high of $2.8 during Q3 2022, and its lowest value of -$0.74 during Q1 2025.
- Its 5-year average for EPS (Weighted Average and Diluted) is $0.54, with a median of $0.46 in 2024.
- In the last 5 years, Innoviva's EPS (Weighted Average and Diluted) tumbled by 285000.0% in 2024 and then surged by 530000.0% in 2025.
- Over the past 5 years, Innoviva's EPS (Weighted Average and Diluted) (Quarter) stood at $0.9 in 2021, then surged by 211.11% to $2.8 in 2022, then plummeted by 65.0% to $0.98 in 2023, then crashed by 97.96% to $0.02 in 2024, then skyrocketed by 5300.0% to $1.08 in 2025.
- Its last three reported values are $1.08 in Q3 2025, $0.77 for Q2 2025, and -$0.74 during Q1 2025.